Finance

Lists
000972:SHE
Chalkis Health Industry Co Ltd
CNÂ¥3.61
-0.82%
(-0.030) 1D
Oct 30, 3:05:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000972...
Open
CNÂ¥3.72
High
CNÂ¥3.91
Low
CNÂ¥3.61
Mkt. cap
2.78B
Avg. vol.
26.50M
Volume
29.46M
52-wk high
CNÂ¥4.81
52-wk low
CNÂ¥3.05
EPS
-CNÂ¥0.03
Shares outstanding
771.28M
No. of employees
367
Open
CNÂ¥3.72
High
CNÂ¥3.91
Low
CNÂ¥3.61
Mkt. cap
2.78B
Avg. vol.
26.50M
Volume
29.46M
52-wk high
CNÂ¥4.81
52-wk low
CNÂ¥3.05
EPS
-CNÂ¥0.03
Shares outstanding
771.28M
No. of employees
367
News stories
From web sources and news partners
Profile
Xinjiang Chalkis Company Ltd is a major Chinese agricultural company that processes tomatoes and fruits, founded in 1994. It also produces conical barrels and wooden ton-boxes. It is headquartered in Urumqi, Xinjiang, China. Xinjiang Chalkis is an export-oriented state-owned enterprise that is supported and developed by the Xinjiang Production and Construction Corps, affiliated to the 6th division. It was established in May 2000 with a registered capital of 371.7 million yuan. The production facilities are mainly located in Xinjiang, Inner Mongolia and Tianjin. By the end of 2005, the company had total assets worth 2.137 billion yuan and an annual sales revenue of more than 700 million yuan. Over 95% of the company's products are exported to the international market. Since 2004, its products constitute 18% of the world's tomato sauce trading volume. Its small-can tomato sauce products account for 60% of the African market share. Since 2009, the company has heavily invested in tomato harvesting mechanization, and harvesting machine leasing is a minor revenue line. Wikipedia
About Chalkis Health Industry Co Ltd
CEO-
Employees367
FoundedJun 30, 1994
Headquarters-
SectorFood
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
137.94M
54.82M
141.99M
90.89M
Cost of goods sold
291.69M
53.92M
181.88M
106.14M
Cost of revenue
291.69M
53.92M
181.88M
106.14M
Research and development expenses
-619.80K
150.00K
928.42K
510.09K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.17M
13.15M
6.21M
9.05M
Operating expense
23.85M
12.75M
9.91M
5.82M
Total operating expenses
315.55M
66.67M
191.79M
111.96M
Operating income
-177.60M
-11.85M
-49.80M
-21.07M
Other non operating income
280.17K
-598.81K
549.93K
-17.50M
EBT including unusual items
96.53M
-20.27M
-49.25M
-54.46M
EBT excluding unusual items
-190.45M
-21.14M
-49.91M
-29.22M
Income tax expense
1.58M
108.79K
-1.43M
1.39M
Effective tax rate
1.63%
-0.54%
2.91%
-2.55%
Other operating expenses
3.08M
36.00K
1.64M
-3.19M
Net income
97.86M
-19.63M
-46.29M
-53.88M
Net profit margin
70.94%
-35.81%
-32.60%
-59.28%
Earnings per share
-
-
-
-
Interest and investment income
168.13K
134.44K
517.52K
8.39M
Interest expense
-12.53M
-8.83M
-
-216.67K
Net interest expenses
-12.37M
-8.69M
517.52K
8.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-168.27M
-2.52M
-41.19M
-11.74M
Gain or loss from assets sale
-3.39M
-
337.67K
-337.67K
Upcoming events
AI content may include mistakes. Learn more
Google apps